TrialPath
← Back to searchRecruiting

Breast Cancer in Pregnancy Register Study

NCT00196833 · GBG Forschungs GmbH
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Prospective and Retrospective Register Study of the German Breast Group (GBG) for Diagnosis and Treatment of Breast Cancer in Pregnancy
About this study
Breast cancer is the most common cancer malignancy in women of childbearing age after the age of 25 years. Since the incidence of breast cancer under the age of 40 is increasing, and women tend to delay pregnancy into later reproductive years, the coincidence of pregnancy and breast cancer is increasing. About 1 in 1,000 pregnancies is complicated by breast cancer. Nevertheless, little is known about the right therapy for the mother and the unborn child. We are therefore carrying out a trial, collecting prospective and retrospective data about pregnant women, with histological confirmed breast cancer. Data on the biology of the tumour and placenta tissues is also collected. The anonymous data is collected in a database.
Eligibility criteria
Inclusion Criteria: * Cohort 1: Women with histologically confirmed breast cancer during pregnancy * Cohort 2: Patients ≤ 40 years with histological confirmed breast cancer who are not pregnant (patients who have been pregnant recently can also be collected into this cohort) * Informed consent for data collection (for prospective participants) and biomaterial collection. For retrospective participants an informed consent is not required as long as the data are anonymously captured Exclusion Criteria: * Cohort 1: Diagnosis of breast cancer outside the period of pregnancy * Cohort 2: Age at diagnosis of breast cancer \> 40 years
Study design
Enrollment target: 1100 participants
Age groups: child, adult, older_adult
Timeline
Starts: 2003-04
Estimated completion: 2026-04
Last updated: 2024-04-17
Sponsor
GBG Forschungs GmbH · other
With: Goethe University
Contacts & investigators
ContactSibylle Loibl, Prof. Dr. · contact · Sibylle.Loibl@gbg.de · +49 6102-7480-
InvestigatorSibylle Loibl, Prof. Dr. · principal_investigator, GBG Forschungs GmbH
All locations (1)
German Breast GroupRecruiting
Neu-Isenburg, Hesse, Germany
Breast Cancer in Pregnancy Register Study · TrialPath